With the successful completion of a second closing, Labforward adds more than three million Euro to the Series B from January, bringing the total funds raised to more than 8.5 million Euro. The majority of the new investment comes from the Fielmann Family Office, majority owner of the leading German family business of the same name that serves its 27 million customers across 15 European markets with eyewear and hearing aids.

Bio-Rad Laboratories announced the launch of the Reliance Sars-Cov-2 RT-PCR Kit (IVD) for European markets after having met the CE-IVD mark requirements.

Norwegian researchers have found that neighbour-cells can take over functions of damaged or missing insulin-producing cells in the pancreas. The discovery may lead to new treatments for diabetes.

Research published in Nature reveals insights into how the body maintains a balance with gut bacteria. Investigations with mice demonstrate that early life is a critical time when the immune system learns to recognize gut bacteria and sets up surveillance that keeps them in check.

Aigenpulse has rolled out an update to its Cyto ML Experiment Suite — its automated, end-to-end, machine learning solution specifically aimed at streamlining and automating cytometry analysis at scale and replacing manual gating processes.

Working together with external partners, chemists, materials scientists and chemical engineers at FAU have developed an innovative microcell for water electrolysis. They hope to replace standard plate electrodes used to split water into oxygen and hydrogen with compact, nanostructured tubes. They aim to simplify production, increase flexibility of use and avoid the need for expensive precious metals.

Scientists have combined artificial intelligence (AI) algorithms with two cutting-edge microscopy techniques — an advance that shortens the time for processing images taken with a microscope from days to mere seconds.

Developer of manufacturing systems for cell and gene therapies, Autolomous, has received a loan from UK Research and Innovation (UKRI), the public innovation agency, as part of the medicine’s manufacturing challenge.

The Cloud Alpha Max is one of Vitrocell's latest innovations and advances the exposure of mammalian cell cultures from the respiratory tract.

Pharmaceutical scientists are now able to overcome challenges associated with the identification and characterization of small molecules and their fragments with Thermo Scientific Mass Frontier 8.0 software, which quickly translates complex data into actionable, sharable knowledge.